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• The above reasons for potential discrepancies will be assessed through simulations
• Data was simulated in R5 under the proportional association structure1,2
• Each scenario consisted of data from 10 simulated studies.  1000 meta-datasets generated 
for each scenario.
• Longitudinal data simulated under linear mixed effects model with variability at individual 
and study level, time-to-event data simulated under Gompertz distribution4.
• As treatment effect would be a measure of interest in the meta-analysis, individuals were 
allocated 1:1 to a binary treatment variable, which was included as a covariate in both sub-
models.
• To test reason 1 (above) data was simulated under cases where 
• all 10 studies included are normal sized (n=200), or all are small (n=25).
• Event is rare (10% of population experienced event) or equal (50% of population 
experienced event) 
2: Data Simulation
Joint models1,2 are methods to simultaneously model potentially related longitudinal and 
time-to-event data.  A sub-model is fitted for each of the longitudinal and time-to-event 
components.  The relationship between the two sub-models is represented through an 
association structure.
Meta-analysis (MA) is the numerical pooling of data from multiple studies and can be one-
stage (where data from all studies is analysed in one model) or two stage (where data from 
each study is analysed separately, and then the study specific results are pooled).
In most cases, results from one and two stage MA are similar, however recent work by Burke 
et al3 identified 10 reasons why results may differ.  This investigation aims to establish the 
extent to which these reasons could cause results from one and two stage joint MA to differ.
This poster focuses on the following reasons for discrepancy (discussed fully in Burke et al3):
1. Exact one-stage likelihood versus approximate two-stage likelihood
• Two stage MA assume study specific treatment effects have a normal sampling 
distribution, and that their variances are known (i.e. that the central limit theory holds, 
and the variances have been accurately estimated)
• This might not hold for small datasets (<30 people), or rare/common events in time-to-
event data
2. Clustering and choice of specification for the intercept
• Naïve to ignore clustering within studies
• Two stage MA automatically account for clustering within studies
• Range of methods to account for clustering in one-stage MA
3. Accounting for correlation amongst parameters
• One stage methods automatically account for correlation between model parameters
• Two stage approaches don’t automatically account for this, unless multivariate meta-
analyses are employed
1: Background
• Standard joint model takes format (for individual 𝑖 in study 𝑘 at time 𝑗) :





Time-to-event sub-model: 𝜆𝑘𝑖 𝑡 = 𝜆0 𝑡 𝑒𝑥𝑝 𝑿𝟐𝒌𝒊𝜷𝟐 +𝑊2𝑘𝑖(𝑡)
Association structure: 𝑊2𝑘𝑖 𝑡 = 𝛼
2 𝒁𝒌𝒊𝒋
𝟐 𝒃𝒌𝒊
𝟐 + 𝛼 3 𝒁𝒌𝒊𝒋
𝟑 𝒃𝒌
𝟑
• Once data had been simulated the methods shown in the table below were fitted to the 
data
• Reason 2 (above) for one and two-stage results differing was examined through the 
range of one-stage methods examined
• Reason 3 (above) for one and two-stage results differing was examined through fitting 
both standard and multivariate two-stage MA
• Parameters of interest extracted were longitudinal and time-to-event treatment effects, 
and association parameters.
• Notes: 
• Two stage MA methods would not contain study fixed effects, or study level random effects, or baseline 
hazard stratified by study
• One stage methods accounting for between study heterogeneity using fixed effects planned but long 
running, results not presented here
• The joineR6, metafor7 and joineRmeta packages were used in these simulations.  Data was simulated 
under code to be released soon in joineRsim (new package)
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• Evidence that discrepancies identified by Burke et al3 for time-to-event data extends to 
joint data analyses especially for rare events, and small datasets
• Important to assess before undertaking meta-analysis (or normal analysis) of joint data 
the event rate, and it’s potential impact on coefficient estimates
• Recommendation to perform both one and two stage analyses to compare the results
• Future work
• Completion of simulations evaluating other reasons presented in Burke et a
• Simulations evaluating varying follow up and event rate defined per year rather than 
“overall” event rate
• Completion of one-stage simulations accounting for between study heterogeneity 
using fixed interaction terms with study membership
• Comparison of Bayesian and frequentist approaches
5: Discussion & Conclusions
• “True” value of parameter shown by black line
• Joint models appear to perform poorly for cases where the studies are all small, and the 
event rate is rare (right hand column)
• Issue most noticeable for association parameters, and time-to-event treatment 
coefficient (bottom 3 rows of graphs) – under scenarios investigated, results for 
longitudinal treatment coefficient treatment was more robust (top row)
• Would be useful to see finer continuum of levels of event rates to examine problem in 
greater detail (ongoing – see further work)
• In reality, there would be concerns fitting a joint model to a dataset containing only 25 
individuals (e.g. in two stage approach) as there is unlikely to be sufficient information to 
properly estimate model parameters – however important to determine whether a one 
stage approach for 10 studies of 25 individuals is feasible.
4: Results
Two stage MA methods examined One stage MA methods examined
Fixed effect standard MA Naïve (ignoring clustering – no fixed 
study effect, or study level random 
effects)
Random effect standard MA Clustering modelled through study 
level random effects 𝒃𝒌
𝟑




baseline hazard by study 𝜆0𝑘 𝑡
Random effect multivariate MA
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